RxDoctor Payments Data

Syed Hassan, MD

Family Medicine · McHenry, ILNPI 1063637544

Payments from drug & device makers

$473in general payments, 2019–2025

Across 33 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$269
  • GSK$55
  • Boehringer Ingelheim$53
  • Merck$36
  • Astellas Pharma US Inc$17
  • Pfizer$17
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$473 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$249,946
Medicare patients
461
Services billed
3,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$86,410
EliquisApixaban52$65,361
JanuviaSitagliptin Phosphate24$38,721
FarxigaDapagliflozin Propanediol27$31,735
OzempicSemaglutide28$28,249
TrulicityDulaglutide24$27,124
XareltoRivaroxaban13$20,126
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$16,366
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$11,009
Breo ElliptaFluticasone/Vilanterol22$10,802
Incruse ElliptaUmeclidinium Bromide13$9,281
Atorvastatin Calcium752$7,735
Metoprolol Succinate274$4,625
Levothyroxine Sodium282$3,196
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$3,156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$53$86,41056 claims
PfizerEliquis$17$65,36152 claims
MerckJanuvia$36$38,72124 claims
AstraZenecaFarxiga$13$31,73527 claims
GSKAnoro Ellipta, Breo Ellipta, Incruse Ellipta$55$31,09256 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in McHenry

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →